Journal ArticleOPEN ACCESS

Heavy/Light Chain Ratio as a Biomarker for Monitoring Patients with IgM Monoclonal Gammopathy and Anti-MAG Neuropathy

  • Planche V
Journal of Hematology & Thromboembolic Diseases (2014) 02(03)
DOI: 10.4172/2329-8790.1000142
N/ACitations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Abstract Background: Patients with neuropathy associated with anti -myelin-associated glycoprotein ( MAG ) antibodies are managed in part by the detection and whenever possible the measurement of IgM -component on serum protein electrophoresis (SPE). Hevylite™ is ...

Cite

CITATION STYLE

APA

Planche, V. (2014). Heavy/Light Chain Ratio as a Biomarker for Monitoring Patients with IgM Monoclonal Gammopathy and Anti-MAG Neuropathy. Journal of Hematology & Thromboembolic Diseases, 02(03). https://doi.org/10.4172/2329-8790.1000142

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free